Scholars Central

Conference abstractPublished 18 Nov 2014

Effect of magnetic tacrine-loaded chitosan nanoparticles on spatial learning, memory, amyloid precursor protein and seladin-1 expression in the hippocampus of streptozotocin-exposed rats

Authors: G Hassanzadeh, Z Fallahi, A Zendedel, M Khanmohammadi, M Sharifzadeh, K Nouri, Z Heydarian, H Elmizadeh, C Beyer, H Kouchesfahani

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Alzheimer�s disease (AD) is a progressive neurodegenerative disease characterized by memory and cognitive dysfunction due to neuronal cell loss in higher braincenters. Senile plaques containing amyloid β (Aβ) and reduction of cholinergicneuron numbers are associated with this disease. Tacrine is a reversible cholinesterase inhibitor in clinical use to treat moderate forms of AD. Chitosan nanoparticles represent an effective systemic delivery system for drugs. The application of tacrine-loaded chitosan nanoparticles selectively increases tacrine concentrations in the brain. In this study, we compared magnetic and non-magnetic tacrine-loaded chitosan nanoparticles for their bioactivity and neuroprotective potency in streptozotocin (stz)- induced neurodegeneration, an accepted animalmodel for AD. Male rats received a single injection of stz via an implanted cannula into the lateral brain ventricle. Tacrine (tac)-loaded chitosan nanoparticles were delivered into the tail vein. Spatial learning and memory were analyzed using the Morris water maze task. Amyloid precursor protein gene (APP) and seladin-1 gene expression were studied in the hippocampus by real time-PCR. Tac-loaded nonmagnetic and tac-loaded magnetic chitosan nanoparticles improved spatial learning and memory after stz treatment with magnetic nanoparticles being most effective. Similarly, tac-loaded chitosan nanoparticles increased seladin-1 and reduced APP gene expression. Again, magnetic nanoparticles were more effective. The data reveal that tac-loaded tac-loaded magnetic chitosan nanoparticles improve brain deficits related to stz application. We conclude that the magnetic target drug delivery system is a promising therapeutic strategy to protect AD-related degenerating in the CNS.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “G Hassanzadeh”
  • BylineArticles whose byline prints “Z Fallahi”
  • BylineArticles whose byline prints “A Zendedel”
  • BylineArticles whose byline prints “M Khanmohammadi”
  • BylineArticles whose byline prints “M Sharifzadeh”
  • BylineArticles whose byline prints “K Nouri”
  • BylineArticles whose byline prints “Z Heydarian”
  • BylineArticles whose byline prints “H Elmizadeh”